Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Welsh

Showing results (741-750 of 858) with videos related to

Pageof 86
Sort By:
Journal of the National Cancer Institute|December 4, 2014
Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancerChunxia Cao, Ruli Gao, Min Zhang, et al.
Cell Chemical Biology|July 2, 2019
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual TargetsNatalia J Sumi, Claudia Ctortecka, Qianqian Hu, et al.
Journal of Extracellular Biology|November 9, 2023
Human red blood cells release microvesicles with distinct sizes and protein composition that alter neutrophil phagocytosisGetulio Pereira de Oliveira Junior, Joshua A Welsh, Brandy Pinckney, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2013
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression StudyDavid Peterson, Caitlin Munger, Jared Crowley, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i> -driven lung cancer via concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Science Signaling|December 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.
The Journal of Infectious Diseases|May 3, 2018
Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective StudyChristina A Muzny, Eugene Blanchard, Christopher M Taylor, et al.
Nature Communications|November 10, 2021
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disordersLuca Pagliaroli, Patrizia Porazzi, Alyxandra T Curtis, et al.
The EMBO Journal|December 23, 2021
Functional conservation and divergence of the helix-turn-helix motif of E2 ubiquitin-conjugating enzymesKaeli A Welsh, Derek L Bolhuis, Anneroos E Nederstigt, et al.
Pageof 86

Showing results (741-750 of 858) with videos related to

Sort By:
Pageof 86
Journal of the National Cancer Institute|December 4, 2014
Role of LKB1-CRTC1 on glycosylated COX-2 and response to COX-2 inhibition in lung cancerChunxia Cao, Ruli Gao, Min Zhang, et al.
Cell Chemical Biology|July 2, 2019
Divergent Polypharmacology-Driven Cellular Activity of Structurally Similar Multi-Kinase Inhibitors through Cumulative Effects on Individual TargetsNatalia J Sumi, Claudia Ctortecka, Qianqian Hu, et al.
Journal of Extracellular Biology|November 9, 2023
Human red blood cells release microvesicles with distinct sizes and protein composition that alter neutrophil phagocytosisGetulio Pereira de Oliveira Junior, Joshua A Welsh, Brandy Pinckney, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 4, 2013
Variants in PPP3R1 and MAPT are associated with more rapid functional decline in Alzheimer's disease: the Cache County Dementia Progression StudyDavid Peterson, Caitlin Munger, Jared Crowley, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i> -driven lung cancer via concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Science Signaling|December 23, 2025
Cancer-associated fibroblasts confer ALK inhibitor resistance in <i>EML4-ALK</i>-driven lung cancer by concurrent integrin and MET signalingQianqian Hu, Lily L Remsing Rix, Bina Desai, et al.
Cell Chemical Biology|July 30, 2021
The non-canonical target PARP16 contributes to polypharmacology of the PARP inhibitor talazoparib and its synergy with WEE1 inhibitorsVinayak Palve, Claire E Knezevic, Daniel S Bejan, et al.
The Journal of Infectious Diseases|May 3, 2018
Identification of Key Bacteria Involved in the Induction of Incident Bacterial Vaginosis: A Prospective StudyChristina A Muzny, Eugene Blanchard, Christopher M Taylor, et al.
Nature Communications|November 10, 2021
Inability to switch from ARID1A-BAF to ARID1B-BAF impairs exit from pluripotency and commitment towards neural crest formation in ARID1B-related neurodevelopmental disordersLuca Pagliaroli, Patrizia Porazzi, Alyxandra T Curtis, et al.
The EMBO Journal|December 23, 2021
Functional conservation and divergence of the helix-turn-helix motif of E2 ubiquitin-conjugating enzymesKaeli A Welsh, Derek L Bolhuis, Anneroos E Nederstigt, et al.
Pageof 86